The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Pulmonary Embolism Global Market Report 2023, the pulmonary embolism market is expected to show promising growth in the forecast period.

The pulmonary embolism market has witnessed rapid growth, surging from $1.81 billion in 2023 to a projected $2.03 billion in 2024, boasting an impressive Compound Annual Growth Rate (CAGR) of 11.9%. This growth in the historic period is attributed to anticoagulant therapies, robust research and clinical trials, increased awareness of pulmonary embolism, and initiatives focused on venous thromboembolism (VTE) prophylaxis. Looking ahead, the forecast anticipates even more rapid growth, reaching $3.2 billion in 2028 at a CAGR of 12.1%. Let’s explore the key drivers, major trends, and the impactful role of cancer prevalence in shaping the future of the pulmonary embolism market.

Increasing Prevalence of Cancer To Drive the Growth of Pulmonary Embolism Market

• Cancer Prevalence Impact
  • Cancer’s uncontrolled cell growth raises the risk of blood clots, including pulmonary embolism.
  • The growing cancer burden drives demand for diagnostics and specialized drugs.
• Global Statistics
  • The National Library of Medicine predicts a 47% rise in global cancer cases to 28.4 million by 2040.
  • The increasing cancer burden highlights the urgent need for effective pulmonary embolism diagnostics and treatments.
• Driving Force
  • The rising prevalence of cancer is a significant driver of the pulmonary embolism market’s growth.

Leading Companies In The Pulmonary Embolism Market Innovate With Advanced Catheter Solutions

• Innovative Catheter Solutions
  • Major companies focus on developing advanced products like the Triever16 Curve catheter and RevCore thrombectomy catheter.
  • Inari Medical Inc. launches the Triever16 Curve catheter designed for peripheral thrombectomy and pulmonary embolism procedures.
• Key Features
  • Triever16 Curve catheter is highly trackable with a pre-shaped curve for focused aspiration.
  • RevCore thrombectomy catheter treats venous in-stent thrombosis using a nitinol basket.
• Impact on Procedures
  • These catheters improve the safety and effectiveness of pulmonary embolism procedures

View More On The Pulmonary Embolism Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Boston Scientific Enhances Vascular Intervention Device Portfolio With Devoro Medical Acquisition

• Acquisition Overview
  • Boston Scientific acquires Devoro Medical Inc. for $336 million in September 2021.
  • Acquisition strengthens Boston Scientific’s vascular intervention device portfolio.
• Innovative Technology
  • Access to Devoro Medical’s Wolf thrombectomy platform for removing blood clots in peripheral blood vessels.
  • Strengthens Boston Scientific’s position in the competitive market for vascular intervention devices.
• Strategic Importance
  • The acquisition enhances Boston Scientific’s capabilities in vascular interventions and adds valuable technologies to its portfolio.

Market Segmentation and Regional Trends

• Market Segmentation
  • By Treatment: Medications, Mechanical Devices, Other Treatments.
  • By Diagnosis: Chest X-Ray, Electrocardiogram (ECG), Magnetic Resonance Imaging (MRI), Computed Tomography Scan, Pulmonary Angiography, Venography, Venous Ultrasound, D-Dimer Test, Other Diagnosis.
  • By Symptoms: Shortness Of Breath, Chest Pain, Cough, Irregular Heartbeat, Dizziness, Fever, Cyanosis, Other Symptoms.
  • By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels.
  • By End-User: Hospitals, Specialty Clinics, Homecare, Other End-Users.
• Regional Trends
  • North America: Dominated the pulmonary embolism market in 2023.
  • Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

Request A Sample Of The Global Pulmonary Embolism Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=13026&type=smp

The Pulmonary Embolism Global Market Report 2023  offers a comprehensive overview on the pulmonary embolism market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the pulmonary embolism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Pulmonary Embolism Market Include:
1. Pulmonary Embolism Market Executive Summary
2. Pulmonary Embolism Market Segments
3. Pulmonary Embolism Market Size And Pulmonary Embolism Market Growth Rate
4. Key Pulmonary Embolism Market Trends
5. Major Pulmonary Embolism Market Drivers
……
25. Key Mergers And Acquisitions In The Pulmonary Embolism Market
26. Top Pulmonary Embolism Companies
27. Pulmonary Embolism Market Opportunities And Strategies
28. Pulmonary Embolism Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
Implantable Cardiac Rhythm Management Device Global Market Report 2023
Cardiac Biomarkers Testing Global Market Report 2023
Cardiac Pacemakers Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/ 
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model